Neurostimulation Devices Market 3
The global Neurostimulation Devices market is expected to reach $11.25 billion by 2026, registering a CAGR of 12.5% from 2019 to 2026.
WILMINGTON, DE, UNITED STATES, September 7, 2024 /EINPresswire.com/ — Neurostimulation Devices Market- Global Outlook and Forecast 2023-2033 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2033). The market Study is segmented by key a region that is accelerating the marketization. The report provides information on market research and development, growth drivers, and the changing investment structure of the Global Neurostimulation Devices Market. Some of the key players profiled in the study are Abbott Laboratories, Aleva Neurotherapeutics, Boston Scientific Corporation, ElectroCore, EndoStim, Medtronic, NeuroPace, Nevro Corporation, Neuronetics, NeuroSigma, Synapse Biomedical. The global Neurostimulation Devices market is expected to reach $11.25 billion by 2026, registering a CAGR of 12.5% from 2019 to 2026.
Click To Get Sample Copy: https://www.alliedmarketresearch.com/request-sample/5558
Neurostimulation Devices Market Key Growth Drivers:
Rising Prevalence of Neurological Disorders: The increasing incidence of neurological conditions such as chronic pain, Parkinson’s disease, epilepsy, depression, and spinal cord injuries is a major driver for neurostimulation devices. These devices offer therapeutic benefits for managing symptoms and improving patients’ quality of life.
Growing Demand For Minimally Invasive Treatments: Neurostimulation devices offer a minimally invasive option for treating chronic neurological conditions, reducing the need for more invasive surgeries. This has driven their adoption in pain management, epilepsy treatment, and movement disorders.
Increasing Aging Population: The global aging population is more susceptible to neurological disorders such as Parkinson’s disease, Alzheimer’s disease, and chronic pain. This demographic shift is leading to a higher demand for neurostimulation therapies to manage these age-related conditions.
Technological Advancements in Neurostimulation Devices: Ongoing innovations, such as smaller, more precise, and rechargeable neurostimulators, as well as devices offering wireless control and real-time feedback, are improving the efficacy and convenience of neurostimulation treatments. These advancements are driving market growth.
Rising Cases of Chronic Pain: Chronic pain conditions such as back pain, sciatica, and neuropathic pain are on the rise due to factors like aging, obesity, and sedentary lifestyles. Spinal cord stimulators and other neurostimulation devices are increasingly being used to manage chronic pain, leading to higher demand.
Growing Adoption of Neurostimulation for Mental Health Disorders: There is an increasing use of neurostimulation devices for treating mental health conditions like depression, anxiety, and obsessive-compulsive disorder (OCD). Devices such as vagus nerve stimulators (VNS) and transcranial magnetic stimulators (TMS) are gaining traction as alternative therapies when traditional treatments are ineffective.
Increasing Awareness of Neurostimulation Therapies: As awareness about the benefits of neurostimulation for managing chronic neurological and pain conditions grows among healthcare providers and patients, there is greater acceptance and adoption of these devices.
Favorable Reimbursement Policies: Government and insurance bodies in various regions are providing coverage for neurostimulation treatments, making these therapies more accessible to patients. Favorable reimbursement policies are supporting market expansion.
Non-Drug Alternatives Amid Opioid Crisis: With increasing concerns about opioid addiction and the overuse of painkillers, neurostimulation devices provide an effective, non-pharmacological alternative for managing chronic pain. This is leading to increased interest from both healthcare providers and patients in pain management without drugs.
Increasing Research and Clinical Trials: Growing research in neurostimulation therapies for various conditions, along with clinical trials demonstrating their effectiveness, is expanding the scope of neurostimulation devices. This has led to broader applications, such as for migraine, incontinence, and stroke rehabilitation.
Have Any Query? Ask Our Expert @: https://www.alliedmarketresearch.com/purchase-enquiry/5558
The segments and sub-section of Neurostimulation Devices market is shown below:
By Device Type: Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others
By Application: Pain Management, Hearing Loss, Urinary Incontinence, Parkinson’s Disease, Epilepsy, and Others
Some of the key players involved in the Market are: Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corporation, ElectroCore, EndoStim, Medtronic, NeuroPace, Nevro Corporation, Neuronetics, NeuroSigma, Synapse Biomedical.
Important years considered in the Neurostimulation Devices study:
Historical year – 2017-2022; Base year – 2023; Forecast period** – 2023 to 2033 [** unless otherwise stated]
If opting for the Global version of Neurostimulation Devices Market; then below country analysis would be included:
– North America (USA, Canada and Mexico)
– Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland and Rest of Europe)
– Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and Rest of APAC)
– South America (Brazil, Argentina, Chile, Colombia, Rest of countries etc.)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)
Introduction about Neurostimulation Devices Market
Neurostimulation Devices Market Size (Sales) Market Share by Type (Product Category)
Neurostimulation Devices Market by Application/End Users
Neurostimulation Devices Sales (Volume) and Market Share Comparison by Applications
Global Neurostimulation Devices Sales and Growth Rate (2023-2033)
Neurostimulation Devices Competition by Players/Suppliers, Region, Type, and Application
Neurostimulation Devices (Volume, Value, and Sales Price) table defined for each geographic region defined.
Neurostimulation Devices Players/Suppliers Profiles and Sales Data
Key Raw Materials Analysis & Price Trends
Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis
……..and view more in complete table of Contents
Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/d261b17ddb398947e53f9911a04acf65
Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Article originally published on www.einpresswire.com as Neurostimulation Devices Market Is Expected To Reach US$11.25 Billion by 2026
